AU2002239607A1 - Ahf associated dispersion system and method for preparation - Google Patents

Ahf associated dispersion system and method for preparation

Info

Publication number
AU2002239607A1
AU2002239607A1 AU2002239607A AU3960702A AU2002239607A1 AU 2002239607 A1 AU2002239607 A1 AU 2002239607A1 AU 2002239607 A AU2002239607 A AU 2002239607A AU 3960702 A AU3960702 A AU 3960702A AU 2002239607 A1 AU2002239607 A1 AU 2002239607A1
Authority
AU
Australia
Prior art keywords
preparation
dispersion system
associated dispersion
ahf
ahf associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002239607A
Inventor
Sathyamangalam V. Balasubramanian
Marc Besman
Ramesh Kashi
Karthik Ramani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of State University of New York
Baxter Healthcare Corp
Original Assignee
Research Foundation of State University of New York
Baxter Healthcare Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Foundation of State University of New York, Baxter Healthcare Corp filed Critical Research Foundation of State University of New York
Publication of AU2002239607A1 publication Critical patent/AU2002239607A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • A61K9/1271Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36Blood coagulation or fibrinolysis factors
    • A61K38/37Factors VIII
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU2002239607A 2000-11-30 2001-11-30 Ahf associated dispersion system and method for preparation Abandoned AU2002239607A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25013700P 2000-11-30 2000-11-30
US60/250,137 2000-11-30
US60250137 2000-11-30
PCT/US2001/048201 WO2002043665A2 (en) 2000-11-30 2001-11-30 Ahf associated dispersion system and method for preparation

Publications (1)

Publication Number Publication Date
AU2002239607A1 true AU2002239607A1 (en) 2002-06-11

Family

ID=22946442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002239607A Abandoned AU2002239607A1 (en) 2000-11-30 2001-11-30 Ahf associated dispersion system and method for preparation

Country Status (3)

Country Link
US (1) US20020132982A1 (en)
AU (1) AU2002239607A1 (en)
WO (1) WO2002043665A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625584B2 (en) 2000-11-30 2009-12-01 The Research Foundation Of State University Of New York Method of complexing a protein by the use of a dispersed system and proteins thereof
US8110218B2 (en) * 2000-11-30 2012-02-07 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein-lipid complexes
US7351688B2 (en) * 2003-02-05 2008-04-01 The Research Foundation Of State University Of New York Compositions and methods for less immunogenic protein formulations
CA2534565C (en) * 2003-08-05 2012-06-19 The Research Foundation Of State University Of New York Reconstitution medium for protein and peptide formulations
EP1898939A2 (en) * 2005-06-29 2008-03-19 The Research Foundation of State of University Of New York at Buffalo Compositions and methods for less immunogenic pr0tein-lip1d complexes
US7662405B2 (en) * 2005-08-09 2010-02-16 The Research Foundation Of State University Of New York Compositions and methods of preparation of liposomal microparticulate IL-12
CA2660310C (en) * 2006-03-30 2015-04-21 The Research Foundation Of State University Of New York Compositions of less immunogenic and long-circulating protein-lipid complexes
US7875288B2 (en) * 2006-03-30 2011-01-25 The Research Foundation Of State University Of New York Method for treating blood coagulation disorders

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3618817A1 (en) * 1986-06-04 1987-12-10 Behringwerke Ag METHOD FOR OBTAINING ACTIVE PROTEINS FROM A BIOLOGICALLY INACTIVE FORM
US5013556A (en) * 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5981714A (en) * 1990-03-05 1999-11-09 Genzyme Corporation Antibodies specific for cystic fibrosis transmembrane conductance regulator and uses therefor
DE4201181A1 (en) * 1992-01-17 1993-07-22 Boehringer Mannheim Gmbh PROCESS FOR STABILIZING PROTEINS
US5679582A (en) * 1993-06-21 1997-10-21 Scriptgen Pharmaceuticals, Inc. Screening method for identifying ligands for target proteins
US6001968A (en) * 1994-08-17 1999-12-14 The Rockefeller University OB polypeptides, modified forms and compositions
US5952198A (en) * 1995-05-04 1999-09-14 Bayer Corporation Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition
EP1079805B1 (en) * 1998-04-27 2004-11-24 Opperbas Holding B.V. Pharmaceutical composition comprising factor viii and neutral liposomes
WO2001025223A1 (en) * 1999-10-06 2001-04-12 The Research Foundation Of State University Of New York Stabilization of taxane-containing dispersed systems

Also Published As

Publication number Publication date
WO2002043665A2 (en) 2002-06-06
US20020132982A1 (en) 2002-09-19
WO2002043665A3 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
AU2001288372A1 (en) System and method for tele-ophthalmology
AU2002215209A1 (en) Content distribution system and content distribution method
AU2001261047A1 (en) Secured content delivery system and method
AU2002214667A1 (en) System and method for rapid telepositioning
AU2001234565A1 (en) System and method for user authentication
AU2001257572A1 (en) Method and system for account activation
AU2002239249A1 (en) System and method for secure network mobility
AU2001292685A1 (en) System and method for delivering security services
AU2001262970A1 (en) Event service method and system
AU2001253567A1 (en) System and method for projecting market penetration
AU2002215785A1 (en) Method and system for enhanced detail-in-context viewing
AU2002213126A1 (en) Method and system for improving vision
AU2001249129A1 (en) Communication system and method
AU2001253877A1 (en) System and method for providing content interruptions
AU2001253325A1 (en) Auction system and method
AU2001247598A1 (en) System and method for customized content delivery
AU2002211657A1 (en) Assessment system and method
WO2002052451A8 (en) Distribution system and method
AU2001251257A1 (en) Brake system and method
AU2001276224A1 (en) Method and system for international shopping
AU2002212605A1 (en) Trading system and method
AU7605400A (en) Method and system for curriculum delivery
AU2001221723A1 (en) Communication method and system
WO2002023370A8 (en) Optimization method and system
AU2001264106A1 (en) Network configuration method and system